Cargando…

250. Blood Stream Infections (BSI) in Pediatric Neuroblastoma High Risk: Emphasis on Viridans Group Streptococci (VGS) Bacteremia

BACKGROUND: Febrile neutropenia’s (FN) literature has focused on acute leukemia and undergoing allogeneic stem cell transplantation (SCT) as high risk factors for microbiological documented infection (MDI) and blood stream infection (BSI). Comprehensive studies on in pediatric Neuroblastoma high ris...

Descripción completa

Detalles Bibliográficos
Autores principales: Alali, Muayad, Hageman, Joseph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777969/
http://dx.doi.org/10.1093/ofid/ofaa439.294
_version_ 1783631027847036928
author Alali, Muayad
Hageman, Joseph
author_facet Alali, Muayad
Hageman, Joseph
author_sort Alali, Muayad
collection PubMed
description BACKGROUND: Febrile neutropenia’s (FN) literature has focused on acute leukemia and undergoing allogeneic stem cell transplantation (SCT) as high risk factors for microbiological documented infection (MDI) and blood stream infection (BSI). Comprehensive studies on in pediatric Neuroblastoma high risk (NB-HR) who receive highly myelosuppressive therapy are lacking. METHODS: We conducted a retrospective medical record review of pediatric patients who received any oncology care at UCM Comer Children’s Hospitals.with a diagnosis of FN who had at least 1 blood culture obtained and one of the following underlying diagnoses (AML, lymphoblastic leukemia ALL), NB-HR, and other solid tumors (ST). SCT patients were excluded from study. We reviewed pathogens isolated from blood cultures (BCx) and determined whether they were pathogens or contaminants using IDSA guidelines. Comparative analyses of BSI rates between NB-HR and other underlying diagnoses were done. RESULTS: A total of 560 FN episodes (FNEs) were identified in 230 patients. FNEs occurred in NB-HR were 102 in 77 patients. Fifty-seven percent of patients developed one or more BSI or MDI during induction chemotherapy. The mean age was 11.0 (SD=6.5) years. True BSI occurred in 138 (24.6%) of FN episodes. The organisms that were most frequently isolated from were viridans group streptococci (VGS) (25%). The highest rate of BSI occurred among FNEs with AML (44/115, 37%) followed by NB-HR 26/110 (25%) Table1. Overall BSI rate in NB-HR group is higher than other solid tumors (25 vs 17%, P=0.03). In subset analysis, VGS bacteremia was highest among FNEs with AML and NB-HR compared with ALL (8.7 and 8.8 % vs 6%) P< 0.04 and P=0.02 respectively. Notably, the gram positive/ gram negative (GP/GN ratio) in NB-HR compared with ST was significantly higher (OR =2.26, CI 95% 1.5–7.8, P< 0.01), this was likely due to a higher VGS rate (8.8% vs 2%, OR=4.2, P < 0.01). Rate of GN-BSI are same in each of ALL,HR-NB and ST. [Image: see text] CONCLUSION: Our large Neuroblastoma cohort showed that NB-HR during induction chemotherapy are higher risk for VGS bacteremia, compared with other solid tumors. Further prospective studies are needed to investigate infection related complication in this high risk group and possible improved morbidity and mortality. DISCLOSURES: All Authors: No reported disclosures
format Online
Article
Text
id pubmed-7777969
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-77779692021-01-07 250. Blood Stream Infections (BSI) in Pediatric Neuroblastoma High Risk: Emphasis on Viridans Group Streptococci (VGS) Bacteremia Alali, Muayad Hageman, Joseph Open Forum Infect Dis Poster Abstracts BACKGROUND: Febrile neutropenia’s (FN) literature has focused on acute leukemia and undergoing allogeneic stem cell transplantation (SCT) as high risk factors for microbiological documented infection (MDI) and blood stream infection (BSI). Comprehensive studies on in pediatric Neuroblastoma high risk (NB-HR) who receive highly myelosuppressive therapy are lacking. METHODS: We conducted a retrospective medical record review of pediatric patients who received any oncology care at UCM Comer Children’s Hospitals.with a diagnosis of FN who had at least 1 blood culture obtained and one of the following underlying diagnoses (AML, lymphoblastic leukemia ALL), NB-HR, and other solid tumors (ST). SCT patients were excluded from study. We reviewed pathogens isolated from blood cultures (BCx) and determined whether they were pathogens or contaminants using IDSA guidelines. Comparative analyses of BSI rates between NB-HR and other underlying diagnoses were done. RESULTS: A total of 560 FN episodes (FNEs) were identified in 230 patients. FNEs occurred in NB-HR were 102 in 77 patients. Fifty-seven percent of patients developed one or more BSI or MDI during induction chemotherapy. The mean age was 11.0 (SD=6.5) years. True BSI occurred in 138 (24.6%) of FN episodes. The organisms that were most frequently isolated from were viridans group streptococci (VGS) (25%). The highest rate of BSI occurred among FNEs with AML (44/115, 37%) followed by NB-HR 26/110 (25%) Table1. Overall BSI rate in NB-HR group is higher than other solid tumors (25 vs 17%, P=0.03). In subset analysis, VGS bacteremia was highest among FNEs with AML and NB-HR compared with ALL (8.7 and 8.8 % vs 6%) P< 0.04 and P=0.02 respectively. Notably, the gram positive/ gram negative (GP/GN ratio) in NB-HR compared with ST was significantly higher (OR =2.26, CI 95% 1.5–7.8, P< 0.01), this was likely due to a higher VGS rate (8.8% vs 2%, OR=4.2, P < 0.01). Rate of GN-BSI are same in each of ALL,HR-NB and ST. [Image: see text] CONCLUSION: Our large Neuroblastoma cohort showed that NB-HR during induction chemotherapy are higher risk for VGS bacteremia, compared with other solid tumors. Further prospective studies are needed to investigate infection related complication in this high risk group and possible improved morbidity and mortality. DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2020-12-31 /pmc/articles/PMC7777969/ http://dx.doi.org/10.1093/ofid/ofaa439.294 Text en © The Author 2020. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Poster Abstracts
Alali, Muayad
Hageman, Joseph
250. Blood Stream Infections (BSI) in Pediatric Neuroblastoma High Risk: Emphasis on Viridans Group Streptococci (VGS) Bacteremia
title 250. Blood Stream Infections (BSI) in Pediatric Neuroblastoma High Risk: Emphasis on Viridans Group Streptococci (VGS) Bacteremia
title_full 250. Blood Stream Infections (BSI) in Pediatric Neuroblastoma High Risk: Emphasis on Viridans Group Streptococci (VGS) Bacteremia
title_fullStr 250. Blood Stream Infections (BSI) in Pediatric Neuroblastoma High Risk: Emphasis on Viridans Group Streptococci (VGS) Bacteremia
title_full_unstemmed 250. Blood Stream Infections (BSI) in Pediatric Neuroblastoma High Risk: Emphasis on Viridans Group Streptococci (VGS) Bacteremia
title_short 250. Blood Stream Infections (BSI) in Pediatric Neuroblastoma High Risk: Emphasis on Viridans Group Streptococci (VGS) Bacteremia
title_sort 250. blood stream infections (bsi) in pediatric neuroblastoma high risk: emphasis on viridans group streptococci (vgs) bacteremia
topic Poster Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777969/
http://dx.doi.org/10.1093/ofid/ofaa439.294
work_keys_str_mv AT alalimuayad 250bloodstreaminfectionsbsiinpediatricneuroblastomahighriskemphasisonviridansgroupstreptococcivgsbacteremia
AT hagemanjoseph 250bloodstreaminfectionsbsiinpediatricneuroblastomahighriskemphasisonviridansgroupstreptococcivgsbacteremia